Anastassios G. Lyras

The impact of hs C-reactive protein and other inflammatory biomarkers on long-term cardiovascular mortality in patients with acute coronary syndromes

Michael N. Zairis, Evdokia N. Adamopoulou, Stavros J. Manousakis et al. · Atherosclerosis · 2006 · 66 citations

Inflammation, Thrombosis, Cardiovascular Disease +13

Early Prognostic Usefulness of C-Reactive Protein Added to the Thrombolysis In Myocardial Infarction Risk Score in Acute Coronary Syndromes

Stefanos Foussas, Michael N. Zairis, Anastassios G. Lyras et al. · The American Journal of Cardiology · 2005 · 64 citations

Thrombosis, Cardiovascular Disease, Myocardial Infarction +13

Type 2 Diabetes and Intravenous Thrombolysis Outcome in the Setting of ST Elevation Myocardial Infarction

Michael N. Zairis, Anastassios G. Lyras, Stamatis S. Makrygiannis et al. · Diabetes Care · 2004 · 42 citations · Full text

Association of inflammatory biomarkers and cardiac troponin I with multifocal activation of coronary artery tree in the setting of non-ST-elevation acute myocardial infarction

Michael N. Zairis, Anastassios G. Lyras, George P. Bibis et al. · Atherosclerosis · 2005 · 37 citations

Inflammation, Percutaneous Coronary Intervention, Cardiovascular Disease +13

Preprocedural plasma C-reactive protein levels, postprocedural creatine kinase-MB release, and long-term prognosis after successful coronary stenting (four-year results from the GENERATION study)

Michael N. Zairis, John A. Ambrose, Olga S. Ampartzidou et al. · The American Journal of Cardiology · 2005 · 11 citations

Thrombosis, Percutaneous Coronary Intervention, Cardiovascular Translational Research +10